Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mehdi Abedi, Samira Sadat Abolmaali, Mozhgan Abedanzadeh, Fatemeh Farjadian, Soliman Mohammadi Samani & Ali Mohammad Tamaddon. (2020) Core–Shell Imidazoline–Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound. International Journal of Nanomedicine 15, pages 2617-2631.
Read now
Read now
Irene Hl Hamelers & Anton Ipm de Kroon. (2007) Nanocapsules: A Novel Formulation Technology For Platinum-Based Anticancer Drugs. Future Lipidology 2:4, pages 445-453.
Read now
Read now
Irene H. L. Hamelers & Anton I. P. M. de Kroon. (2007) Nanocapsules: A Novel Lipid Formulation Platform for Platinum-based Anti-cancer Drugs. Journal of Liposome Research 17:3-4, pages 183-189.
Read now
Read now
Articles from other publishers (32)
Si Ying Lim, Zhi En Low, Regina Pei Woon Tan, Zhi Chiaw Lim, Wee Han Ang, Tetsuo Kubota, Michiko Yamanaka, Steven Pang, Erhan Simsek & Sam Fong Yau Li. (2022) Single-cell and bulk ICP–MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models. Metallomics 14:12.
Crossref
Crossref
Yaman Alghamian, Chadi Soukkarieh, Abdul Qader Abbady & Hossam Murad. (2022) Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line. Scientific Reports 12:1.
Crossref
Crossref
Martin Sojka, Jan Chyba, Shib Shankar Paul, Karolina Wawrocka, Kateřina Hönigová, Ben Joseph R. Cuyacot, Abril C. Castro, Tomáš Vaculovič, Jaromír Marek, Michal Repisky, Michal Masařík, Jan Novotný & Radek Marek. (2021) Supramolecular Coronation of Platinum(II) Complexes by Macrocycles: Structure, Relativistic DFT Calculations, and Biological Effects. Inorganic Chemistry 60:23, pages 17911-17925.
Crossref
Crossref
Ze Yu, Weifan Cao, Yuan Ren, Qijia Zhang & Jia Liu. (2020) ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells. Clinical and Translational Medicine 10:1, pages 57-73.
Crossref
Crossref
I. Buß, A. Hamacher, N. Sarin, M. U. Kassack & G. V. Kalayda. (2018) Relevance of copper transporter 1 and organic cation transporters 1–3 for oxaliplatin uptake and drug resistance in colorectal cancer cells. Metallomics 10:3, pages 414-425.
Crossref
Crossref
T. Marino, A. Parise & N. Russo. (2017)
The role of arsenic in the hydrolysis and DNA metalation processes in an arsenous acid–platinum(
ii
) anticancer complex
. Physical Chemistry Chemical Physics 19:2, pages 1328-1334.
Crossref
Crossref
Szu-Jung Chen, Ching-Chuan Kuo, Hsin-Yi Pan, Tsui-Chun Tsou, Szu-Ching Yeh & Jang-Yang Chang. (2016)
Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells
in vitro
and
in vivo
. Oncotarget 7:31, pages 49310-49321.
Crossref
Crossref
Haiyan Yu, Shaohua Gou, Zhimei Wang, Feihong Chen & Lei Fang. (2016) Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes. European Journal of Medicinal Chemistry 114, pages 141-152.
Crossref
Crossref
Yuming Wei, Kenneth K.W. To & Steve C.F. Au-Yeung. (2015) Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cells. Journal of Pharmacological Sciences 129:4, pages 210-215.
Crossref
Crossref
Eva Martinez-Balibrea, Anna Martínez-Cardús, Alba Ginés, Vicenç Ruiz de Porras, Catia Moutinho, Laura Layos, José Luis Manzano, Cristina Bugés, Sara Bystrup, Manel Esteller & Albert Abad. (2015) Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance. Molecular Cancer Therapeutics 14:8, pages 1767-1776.
Crossref
Crossref
Szu-Jung Chen, Ching-Chuan Kuo, Hsin-Yi Pan, Tsui-Chun Tsou, Szu-Ching Yeh & Jang-Yang Chang. (2015) Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo. Biochemical Pharmacology 95:1, pages 28-37.
Crossref
Crossref
King Leung Fung, Abisola K. Tepede, Kristen M. Pluchino, Lynn M. Pouliot, Jessica N. Pixley, Matthew D. Hall & Michael M. Gottesman. (2014)
Uptake of Compounds That Selectively Kill Multidrug-Resistant Cells: The Copper Transporter
SLC31A1
(CTR1) Increases Cellular Accumulation of the Thiosemicarbazone NSC73306
. Molecular Pharmaceutics 11:8, pages 2692-2702.
Crossref
Crossref
Ludmila Szabova, Sujata Bupp, Muhaymin Kamal, Deborah B. Householder, Lidia Hernandez, Jerome J. Schlomer, Maureen L. Baran, Ming Yi, Robert M. Stephens, Christina M. Annunziata, Philip L. Martin, Terry A. Van Dyke, Zoe Weaver Ohler & Simone Difilippantonio. (2014) Pathway-Specific Engineered Mouse Allograft Models Functionally Recapitulate Human Serous Epithelial Ovarian Cancer. PLoS ONE 9:4, pages e95649.
Crossref
Crossref
Mariusz Panczyk. (2014) Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World Journal of Gastroenterology 20:29, pages 9775.
Crossref
Crossref
Elden P. Swindell, Patrick L. Hankins, Haimei Chen, Đenana U. Miodragović & Thomas V. O’Halloran. (2013) Anticancer Activity of Small-Molecule and Nanoparticulate Arsenic(III) Complexes. Inorganic Chemistry 52:21, pages 12292-12304.
Crossref
Crossref
Ðenana U. Miodragović, Jeremy A. Quentzel, Josh W. Kurutz, Charlotte L. Stern, Richard W. Ahn, Irawati Kandela, Andrew Mazar & Thomas V. O'Halloran. (2013) Robust Structure and Reactivity of Aqueous Arsenous Acid–Platinum(II) Anticancer Complexes. Angewandte Chemie International Edition 52:41, pages 10749-10752.
Crossref
Crossref
Ðenana U. Miodragović, Jeremy A. Quentzel, Josh W. Kurutz, Charlotte L. Stern, Richard W. Ahn, Irawati Kandela, Andrew Mazar & Thomas V. O'Halloran. (2013) Robust Structure and Reactivity of Aqueous Arsenous Acid-Platinum(II) Anticancer Complexes. Angewandte Chemie 125:41, pages 10949-10952.
Crossref
Crossref
Verena Schneider, Michaela L. Krieger, Gerd Bendas, Ulrich Jaehde & Ganna V. Kalayda. (2012) Contribution of intracellular ATP to cisplatin resistance of tumor cells. JBIC Journal of Biological Inorganic Chemistry 18:2, pages 165-174.
Crossref
Crossref
Ganna V. Kalayda, Christina H. Wagner & Ulrich Jaehde. (2012) Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells. Journal of Inorganic Biochemistry 116, pages 1-10.
Crossref
Crossref
Jason A. Sprowl, Torben S. Mikkelsen, Hugh Giovinazzo & Alex Sparreboom. (2012) Contribution of tumoral and host solute carriers to clinical drug response. Drug Resistance Updates 15:1-2, pages 5-20.
Crossref
Crossref
Ansgar Brüning & Ioannis Mylonas. (2010) New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer. Archives of Gynecology and Obstetrics 283:5, pages 1087-1096.
Crossref
Crossref
Herman Burger, Walter J. Loos, Karel Eechoute, Jaap Verweij, Ron H.J. Mathijssen & Erik A.C. Wiemer. (2011) Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resistance Updates 14:1, pages 22-34.
Crossref
Crossref
Michael Agrez, Madhu Garg, Douglas Dorahy & Stephen Ackland. (2011) Synergistic Anti-Tumor Effect of Cisplatin When Combined with an Anti-Src Kinase Integrin-Based Peptide. Journal of Cancer Therapy 02:03, pages 295-301.
Crossref
Crossref
H Burger, A Zoumaro-Djayoon, AWM Boersma, J Helleman, EMJJ Berns, RHJ Mathijssen, WJ Loos & EAC Wiemer. (2010) Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2). British Journal of Pharmacology 159:4, pages 898-908.
Crossref
Crossref
Susanne BrydeAnton IPM de Kroon. (2009) Nanocapsules of platinum anticancer drugs: development towards therapeutic use. Future Medicinal Chemistry 1:8, pages 1467-1480.
Crossref
Crossref
Irene H.L. Hamelers, Rutger W.H.M. Staffhorst, Jarno Voortman, Ben de Kruijff, Jan Reedijk, Paul M.P. van Bergen en Henegouwen & Anton I.P.M. de Kroon. (2009) High Cytotoxicity of Cisplatin Nanocapsules in Ovarian Carcinoma Cells Depends on Uptake by Caveolae-Mediated Endocytosis. Clinical Cancer Research 15:4, pages 1259-1268.
Crossref
Crossref
Irene H.L. Hamelers & Anton I.P.M. de Kroon. 2009. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy
27
32
.
Ivo Fabrik, Sona Krizkova, Dalibor Huska, Vojtech Adam, Jaromir Hubalek, Libuse Trnkova, Tomas Eckschlager, Jiri Kukacka, Richard Prusa & Rene Kizek. (2008) Employment of Electrochemical Techniques for Metallothionein Determination in Tumor Cell Lines and Patients with a Tumor Disease. Electroanalysis 20:14, pages 1521-1532.
Crossref
Crossref
Matthew D. HallMitsunori OkabeDing-Wu ShenXing-Jie LiangMichael M. Gottesman. (2008) The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy. Annual Review of Pharmacology and Toxicology 48:1, pages 495-535.
Crossref
Crossref
Petra Heffeter, Ute Jungwirth, Michael Jakupec, Christian Hartinger, Mathea S. Galanski, Leonilla Elbling, Michael Micksche, Bernhard Keppler & Walter Berger. (2008) Resistance against novel anticancer metal compounds: Differences and similarities. Drug Resistance Updates 11:1-2, pages 1-16.
Crossref
Crossref
Britta Stordal, Nick Pavlakis & Ross Davey. (2007) A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship. Cancer Treatment Reviews 33:8, pages 688-703.
Crossref
Crossref
Min-Koo Choi & Dae-Duk Kim. (2006) Platinum transporters and drug resistance. Archives of Pharmacal Research 29:12, pages 1067-1073.
Crossref
Crossref